FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993082783> ?p ?o ?g. }

• W1993082783 endingPage "973" @default.
• W1993082783 startingPage "965" @default.
• W1993082783 abstract "Preferential amplification of low dose-rate irradiation toxicity in tumor cells is one way of improving presently applied brachytherapy. Low temperature hyperthermia applied to a tumor volume during irradiation is one candidate for reaching this goal. The ranges of relevant temperatures and dose-rate have been determined in a tissue culture system. In addition, the role of inhibition of sublethal damage repair in inhibition of dose-rate sparing has been investigated.Dose-rate modification by long duration, mild hyperthermia was investigated in rat 9L gliosarcoma cells at dose-rates between 0.0833 and 132 Gy/hr. Enhancement of toxicity was measured using the colony formation technique.A biphasic dose-rate effect curve was observed when cells were irradiated at 37 degrees C. The dose required to kill 99% of cells irradiated at 37 degrees C increased sharply between 20 and 5 Gy/hr and also below 1 Gy/hr. When cells were irradiated at 41 degrees C, dose-rate sparing disappeared from 132 to 0.0833 Gy/hr. Elimination of dose-rate sparing appeared to be caused by both inhibition of sublethal damage repair and blockage of cell proliferation. The temperature threshold for sensitizing low dose-rate irradiation was determined at temperatures between 24 degrees C and 41 degrees C during 0.5 Gy/hr irradiation. Temperature dependent sensitization occurred above 39 degrees C. The mechanisms by which low temperature hyperthermia sensitizes low dose-rate irradiation was investigated using split dose experiments. Survival curve shoulder recovery was inhibited when cells were incubated at 41 degrees C between acute irradiations. This effect appeared to be caused by both inhibition of recovery from sublethal damage from the first radiation and preheating sensitization of the second irradiation. In single acute dose experiments, sensitization from preheating at 41 degrees C increased gradually over a 6 hr period.The mechanism by which 41 degrees C hyperthermia sensitizes low dose-rate irradiation is inhibition of radiation repair at medium dose rates and inhibition of repair and proliferation at very low dose rates. If low temperature hyperthermia is able to sensitize human tumor cells to brachytherapy similar to what has been described with 9L gliosarcoma cells, the addition of this modality could potentially greatly improve presently applied therapy." @default.
• W1993082783 created "2016-06-24" @default.
• W1993082783 creator A5048592635 @default.
• W1993082783 creator A5059255743 @default.
• W1993082783 creator A5069890928 @default.
• W1993082783 creator A5081161443 @default.
• W1993082783 date "1992-01-01" @default.
• W1993082783 modified "2023-10-14" @default.
• W1993082783 title "Elimination of dose-rate effects by mild hyperthermia" @default.
• W1993082783 cites W1612353714 @default.
• W1993082783 cites W1963674141 @default.
• W1993082783 cites W1974470294 @default.
• W1993082783 cites W1984296893 @default.
• W1993082783 cites W1987632419 @default.
• W1993082783 cites W1996710583 @default.
• W1993082783 cites W2002910462 @default.
• W1993082783 cites W2003297890 @default.
• W1993082783 cites W2009459360 @default.
• W1993082783 cites W2009938756 @default.
• W1993082783 cites W2010818095 @default.
• W1993082783 cites W2021979021 @default.
• W1993082783 cites W2025083544 @default.
• W1993082783 cites W2035745510 @default.
• W1993082783 cites W2043361493 @default.
• W1993082783 cites W2049945035 @default.
• W1993082783 cites W2058106692 @default.
• W1993082783 cites W2084716341 @default.
• W1993082783 cites W2085486779 @default.
• W1993082783 cites W2086171965 @default.
• W1993082783 cites W2092024987 @default.
• W1993082783 cites W2114904724 @default.
• W1993082783 cites W2141519886 @default.
• W1993082783 cites W2146702450 @default.
• W1993082783 cites W2325517415 @default.
• W1993082783 cites W4246715424 @default.
• W1993082783 cites W4320995249 @default.
• W1993082783 doi "https://doi.org/10.1016/0360-3016(92)90481-v" @default.
• W1993082783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1447038" @default.
• W1993082783 hasPublicationYear "1992" @default.
• W1993082783 type Work @default.
• W1993082783 sameAs 1993082783 @default.
• W1993082783 citedByCount "39" @default.
• W1993082783 countsByYear W19930827832012 @default.
• W1993082783 countsByYear W19930827832016 @default.
• W1993082783 countsByYear W19930827832019 @default.
• W1993082783 countsByYear W19930827832021 @default.
• W1993082783 crossrefType "journal-article" @default.
• W1993082783 hasAuthorship W1993082783A5048592635 @default.
• W1993082783 hasAuthorship W1993082783A5059255743 @default.
• W1993082783 hasAuthorship W1993082783A5069890928 @default.
• W1993082783 hasAuthorship W1993082783A5081161443 @default.
• W1993082783 hasBestOaLocation W19930827831 @default.
• W1993082783 hasConcept C111337013 @default.
• W1993082783 hasConcept C121332964 @default.
• W1993082783 hasConcept C126322002 @default.
• W1993082783 hasConcept C16685009 @default.
• W1993082783 hasConcept C185544564 @default.
• W1993082783 hasConcept C19527891 @default.
• W1993082783 hasConcept C203014093 @default.
• W1993082783 hasConcept C2776194525 @default.
• W1993082783 hasConcept C2776217527 @default.
• W1993082783 hasConcept C2777295375 @default.
• W1993082783 hasConcept C2779949491 @default.
• W1993082783 hasConcept C29730261 @default.
• W1993082783 hasConcept C2989005 @default.
• W1993082783 hasConcept C3017588741 @default.
• W1993082783 hasConcept C502942594 @default.
• W1993082783 hasConcept C71924100 @default.
• W1993082783 hasConcept C79410662 @default.
• W1993082783 hasConcept C98274493 @default.
• W1993082783 hasConceptScore W1993082783C111337013 @default.
• W1993082783 hasConceptScore W1993082783C121332964 @default.
• W1993082783 hasConceptScore W1993082783C126322002 @default.
• W1993082783 hasConceptScore W1993082783C16685009 @default.
• W1993082783 hasConceptScore W1993082783C185544564 @default.
• W1993082783 hasConceptScore W1993082783C19527891 @default.
• W1993082783 hasConceptScore W1993082783C203014093 @default.
• W1993082783 hasConceptScore W1993082783C2776194525 @default.
• W1993082783 hasConceptScore W1993082783C2776217527 @default.
• W1993082783 hasConceptScore W1993082783C2777295375 @default.
• W1993082783 hasConceptScore W1993082783C2779949491 @default.
• W1993082783 hasConceptScore W1993082783C29730261 @default.
• W1993082783 hasConceptScore W1993082783C2989005 @default.
• W1993082783 hasConceptScore W1993082783C3017588741 @default.
• W1993082783 hasConceptScore W1993082783C502942594 @default.
• W1993082783 hasConceptScore W1993082783C71924100 @default.
• W1993082783 hasConceptScore W1993082783C79410662 @default.
• W1993082783 hasConceptScore W1993082783C98274493 @default.
• W1993082783 hasIssue "5" @default.
• W1993082783 hasLocation W19930827831 @default.
• W1993082783 hasLocation W19930827832 @default.
• W1993082783 hasOpenAccess W1993082783 @default.
• W1993082783 hasPrimaryLocation W19930827831 @default.
• W1993082783 hasRelatedWork W1982664132 @default.
• W1993082783 hasRelatedWork W1993082783 @default.
• W1993082783 hasRelatedWork W2047186824 @default.
• W1993082783 hasRelatedWork W2049945035 @default.
• W1993082783 hasRelatedWork W2077990344 @default.

• next